eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
Share:
Send email
Share:
Letter to the Editor

SAFETY OF GLP-1RA THERAPY: SIDE EFFECTS AND THE NEED FOR MONITORING

Małgorzata Teresa Piasta
1
,
Miłosz Mandryk
2
,
Magdalena Grzesiak
3
,
Oskar Szymański
3

  1. Voivodeship Hospital in Kielce, Poland
  2. 4th Military Clinical Hospital, Wroclaw, Poland
  3. University Hospital in Wroclaw, Poland
Health Prob Civil.
DOI: https://doi.org/10.5114/hpc.2024.142668
Online publish date: 2024/09/20
Article file
- Piasta et al.pdf  [0.25 MB]
Get citation
 
PlumX metrics:
 
1. Bieganek P, Sadłowski B, Łukaszewicz S, Pawłowski P, Rybak J, Kordialik J, et al. Newly-emerging side effects of semaglutide and liraglutide usage associated with weight loss treatment. Health Prob Civil. Forthcoming 2024. https://doi.org/10.5114/hpc.2024.140505
2. Drucker DJ. Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity. Diabetes Care. 2024; dci240003. https://doi.org/10.2337/dci24-0003
3. Yang Z, Lv Y, Yu M, Mei M, Xiang L, Zhao S, et al. GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS. Front. Pharmacol. 2022; 13:925377. https://doi.org/10.3389/fphar.2022.925377
4. Silverii GA, Monami M, Gallo M, Ragni A , Prattichizzo F, Renzelli V, et al. Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2024; 26(3): 891-900. https://doi.org/10.1111/dom.15382
Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.